Share this page | Email | Contact Us

Special Report on

Marketing and Advertising of Pharmaceuticals

marketing and advertising of pharmaceuticals special research report Photo by
— A new study by two York University researchers estimates the U.S. pharmaceutical industry spends almost twice as much on promotion as it does on research and development, contrary to the industry’s claim. The researchers’ estimate is based on the systematic collection of data directly from the industry and doctors during 2004, which shows the U.S. pharmaceutical industry spent 24.4% of the sales dollar on promotion, versus 13.4% for research and development, as a percentage of US domestic sales of US$235.4 billion. The research is co-authored by PhD candidate Marc-André Gagnon, who led the study with ...
Evidences show that marketing practices can negatively affect both patients and the health care profession. Many countries have measures in place to limit advertising by pharmaceutical companies . Pharmaceutical company spending on marketing far exceeds that spend on research. 1 In Canada, $1.7 billion was spent in 2004 to market drugs to physicians; in the United States, $21 billion was spent in 2002. 2 In 2005 money spent on pharmaceutical marketing in the US was estimated at $29.9 billion with one estimate as high as $57 billion. 1 When the US number are broken down 56% was free samples, 25% was detailing of physicians, 12.5% ...
Q&A With KIT Digital's CEO Kaleil Isaza Tuzman | The Business Of ...
Each week I spend a lot of time trading emails with CEOs in the industry and simply due to time restraints, many of the conversations never go up on my blog. While probably half of what they tell me I'm not able to disclose anyway, there is a lot of information they share that I can make public, especially when it comes to the trends they are seeing in the market. With that in mind, this post with KIT Digital's CEO Kaleil Isaza Tuzman kicks off a new CEO Q&A format that I am going to try and do each week on my blog. If you want your company interviewed, send me an email and let me know as I already have a bunch ... market research, surveys and trends
peHUB » Alcon Buying LensX Lasers for $744 Million
an Aliso Viejo, Calif.-based maker of cataract surgery lasers. The deal includes a $361.5 million up-front cash payment, plus up to $382.5 million in milestone payments. LensX has raised nearly $32 million in VC funding from Versant Ventures, InterWest Partners and SV Life Sciences. The LenxX founding team is the same group that founded IntraLase, a VC-backed company acquired by AMO in 2007 for $808 million. PRESS RELEASE Alcon, Inc. (NYSE: ACL ) announced today that it has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive U.S. Food ... market research, surveys and trends


Beyond Advertising: The Pharmaceutical Industry's Hidden Marketing ...
feature Dr. Robert Jarvik, a pioneer in the development of the artificial heart. Viewers are not told that Jarvik is not a cardiologist, nor is he licensed to practice medicine. His presentation as a trusted expert, Pfizer presumably hopes, is enough to persuade viewers to ask their doctors for Lipitor by name. And that would help erode the increasing competition from generic alternatives. DTC ads have been controversial since the Food and Drug Administration (FDA) loosened the rules governing pharmaceutical marketing in 1997. Before Lipitor made headlines, there was Viagra. Pfizer's "Viva Viagra!" campaign was ... industry trends, business articles and survey research
TNS Media Intelligence Reports US Advertising Expenditures ...
– Total advertising expenditures in 2006 increased 4.1 percent to $149.6 billion as compared to 2005, according to data released today by TNS Media Intelligence, the leading provider of strategic advertising and marketing information. Ad spending during the fourth quarter of 2006 was up by 4.2 percent against the same period in 2005. “Total advertising expenditures continue to expand slowly. Excluding the cyclical contributions from special events such as political elections and the Olympics, core growth is tracking ... industry trends, business articles and survey research
JEREMY HEISLER, New York, New York (David W. Sanford, Katherine M. Kimpel, Sanford, Wittels & Heisler, Washington, D.C., Steven Wittels, Andrew Melzer, Sanford, Wittels & Heisler, New York, New York, on the brief), for Plaintiffs-Appellants. RICHARD H. SCHNADIG, Chicago, Illinois (Vedder Price, Chicago, Illinois, Jonathan A. Wexler, Vedder Price, New York, New York, on the brief), for Defendant-Appellee. JENNIFER R. MARION, United States Department of Labor, Washington, D.C. (Carol A. De Deo, Deputy Solicitor for National Operations, William C. Lesser, Deputy Associate Solicitor, Paul L. Frieden, Counsel for Appellate ... market trends, news research and surveys resources
Symbollon Forms Joint Venture with Internet Marketing Consortium to Promote ...
has announced today it has signed a non-exclusive joint venture agreement with Internet Marketing Consortium (IMC) to promote Iogen(TM). The purpose of the joint venture is to utilize the proprietary internet and multi-media marketing strategies and networks to promote Iogen(TM) through website sales on . IMC is part of Beryl Wolk's family-owned businesses comprising 27 autonomous companies, employing 1,250 employees, with major facilities in four states and 66 offices worldwide. The parties will share 50/50% in the profits of the joint venture. Iogen(TM) is the first dietary supplement formulated to ... market trends, news research and surveys resources


Direct-to-Consumer Advertising (DTC) of Pharmaceuticals
Feb 4, 2008 ... Consumer opinion and effectiveness of direct-to- consumer advertising. Journal of Consumer Marketing 24(5), pp. 283-292. ... technology research, surveys study and trend statistics
GAO-03-177 Prescription Drugs: FDA Oversight of Direct-to-Consumer ...
advertised drug.3 The Division of Drug Marketing, Advertising, and ..... In some drug categories, a small number of pharmaceuticals ... technology research, surveys study and trend statistics
Direct-to-Consumer Advertising of Prescription Drugs
Appropriations for CDER's Division of Drug Marketing, Advertising, .... of all promotional spending for pharmaceuticals; when the retail value of samples is ...
latest webinars
  1. Freedom Forex Formula Training and Q&A Webinar
  2. HealthMedia® - Webinar Library
Join these Webinars to learn more about current research, trends and surveys.
Which sectors tend to have the highest market research spend, and ...
Government Services (4), Offshoring and Outsourcing (3), Business Development (3), Government Policy (2), Exporting/Importing (2), Sales Techniques (2), Manufacturing (2), Energy and Development (2), Air Travel (1), Public Funding (1), Treaties, Agreements and Organizations (1), Customs, Tariffs and Taxes (1), Advertising (1), Project Management (1), Engineering (1), Product Design (1), Positioning (1), Green Business (1) pharma industry - because they make so much money, and they need it and they can afford it posted 2 months ago BDE at Web Notes Tech - Online ERP Solution see all my answers Best Answers in: Business Analytics ...
New Adwords Policy for Pharmaceuticals
I can't help but think that pressure from "Big Pharma" is extending its tentacles into the search engine world to protect bloated profits. The first two points make good sense, however the third policy point could be open to interpretation and to me could potentially exclude all importation into U.S. of "generic" drugs which cost much, much less that "brand" drugs. Am I off base here? Looking forward to other opinions. clearly indicate on your website that an existing prescription is required to purchase prescription drugs. Pharmaceutical ads may not target the UK for any reason. Ads or keywords to the United States for ...